|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 519/00 | |
| C07D 487/04 |
| (11) | Patento numeris | 3177624 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760263.2 |
| Europos patento paraiškos padavimo data | 2015-07-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/055597 |
| Data | 2015-07-23 |
| (87) | Numeris | WO 2016/020786 |
| Data | 2016-02-11 |
| (30) | Numeris | Data | Šalis |
| 201462033684 P | 2014-08-06 | US | |
| 201562157129 P | 2015-05-05 | US |
| (72) |
CHAPPIE, Thomas Allen, US
HAYWARD, Matthew Merrill, US
HELAL, Christopher John, US
LACHAPELLE, Erik Alphie, US
PATEL, Nandini Chaturbhai, US
SCIABOLA, Simone, US
VERHOEST, Patrick Robert, US
YOUNG, Joseph Michael, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMIDAZOPYRIDAZINE COMPOUNDS |
| IMIDAZOPYRIDAZINE COMPOUNDS |